|
Volume 272, Number 11,
Issue of March 14, 1997
pp. 7211-7222
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Organized Endothelial Cell Surface Signal Transduction in
Caveolae Distinct from Glycosylphosphatidylinositol-anchored Protein
Microdomains*
(Received for publication, October 16, 1996, and in revised form, December 9, 1996)
Jun
Liu
,
Phil
Oh
,
Thierry
Horner
,
Rick A.
Rogers
and
Jan E.
Schnitzer
§
From the Department of Pathology, Harvard Medical School, Beth
Israel Deaconess Medical Center, Boston, Massachusetts 02215 and the
Department of Environmental Health, Harvard School of
Public Health, Boston, Massachusetts 02115
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Regulated signal transduction in discrete
microdomains of the cell surface is an attractive hypothesis for
achieving spatial and temporal specificity in signaling. A procedure
for purifying caveolae separately from other similarly buoyant
microdomains including those rich in
glycosylphosphatidylinositol-anchored proteins has been developed
(Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J., and Oh, P. (1995) Science 269, 1435-1439) and used here to show that
caveolae contain many signaling molecules including select kinases
(platelet-derived growth factor (PDGF) receptors, protein kinase C,
phosphatidylinositol 3-kinase, and Src-like kinases), phospholipase C,
sphingomyelin, and even phosphoinositides. More importantly, two
different techniques reveal that caveolae function as signal
transducing subcompartments of the plasma membrane. PDGF rapidly
induces phosphorylation of endothelial cell plasmalemmal proteins
residing in caveolae as detected by membrane subfractionation and
confocal immunofluorescence microscopy. This PDGF signaling cascade is
halted when the caveolar compartment is disassembled by filipin.
Finally, in vitro kinase assays show that caveolae contain
most of the intrinsic tyrosine kinase activity of the plasma membrane.
As signal transducing organelles, caveolae organize a distinct set of
signaling molecules to permit direct regionalized signal transduction
within their boundaries.
INTRODUCTION
A fundamental question in signal transduction is how particular
substrates are rapidly and specifically phosphorylated by select
protein kinases. Because various signaling molecules can rather
promiscuously activate a diverse group of effectors in different
signaling pathways, a developing theme in signal transduction has been
the importance of the intracellular location of signaling molecules,
especially protein kinases, through regulated anchoring to membranes
(1). Restricted localization, for instance to the plasma membrane, of
the kinases and substrates to their sites of action provides at least
some of the specificity and efficiency in the effects mediated by each
kinase. By extension, further compartmentalization of signaling
mediators into specialized microdomains, for instance at the cell
surface, may be required to direct a coordinated cascade that
effectively creates a specific signal and effect on the cell. Here, we
begin to investigate this hypothesis by examining cell surface
signaling in endothelium and its caveolae.
Caveolae are specialized microdomains that appear as flask-shaped
invaginations on the surface of many cells. Based primarily on
morphological studies providing evidence for agonist-induced clustering
in caveolae of G-protein coupled receptors ( -adrenergic and
muscarinic acetylcholine receptors), Strosberg (2) hypothesized 6 years
ago that caveolae may participate in cell surface signaling. Caveolae
may contain the necessary molecular machinery for mediating compartmentalized signaling. They are reported to be resistant to
Triton X-100 solubilization and can be found in Triton-insoluble membranes (TIM)1 (3-5). TIM isolated from
MDCK cells contain large amounts of sphingomyelin, glycosphingolipids
and cholesterol (6). TIM may also contain phosphoinositides, as
reported by one group (7) but not another (6). Various TIM preparations
(3, 4, 6, 8, 9) have been shown to contain molecules implicated in cell
surface signaling including glycosylphosphatidylinositol (GPI)-anchored
proteins, GTP-binding proteins, Src-like nonreceptor tyrosine kinases
(NRTK), protein kinase C (PKC), and caveolin/VIP-21. Although
Triton-insolubility of a membrane protein has been considered a
standard hallmark of cytoskeletal association over 2 decades (10, 11),
some investigators have chosen to consider TIM as equivalent to
purified caveolae, leading to their proposal that caveolae function in
cell surface signaling (4, 12, 13).
More recent work brings this presumed equivalence into serious doubt.
Careful examination of the membrane topology and subcellular localization of caveolin/VIP-21, GPI-anchored proteins, and
glycosphingolipids reveals that they are located both in the
trans-Golgi network as well as in plasmalemmal microdomains (6, 14,
15), indicating that at least two different domains can contribute to
the caveolin-containing TIM isolated from whole cells or tissues. Even
when starting with highly purified plasma membranes, at least two TIM
microdomains, namely caveolae and GPI-anchored protein microdomains,
exist distinctly and have been purified separately (15). Caveolae not
concentrated in GPI-anchored proteins have been purified both in the
presence and absence of Triton X-100; they are highly enriched in all
four caveolar markers previously identified by electron microscopy including caveolin, Ca2+ ATPase, inositol trisphosphate
receptors, and the cholera toxin-binding glycolipid GM1
(15, 16). Colloidal gold localization by electron microscopy confirms
that the TIM consist of many large vesicles (>200 nm) rich in
GPI-anchored proteins along with smaller caveolar vesicles (<100 nm)
lacking them (15). Moreover, caveolae need not be present for TIM
isolation; TIM from cells without caveolae consist of many large
vesicles (>200 nm) containing multiple GPI-anchored proteins and NRTK
but not caveolin (17, 18). TIM isolated from cell membranes with or
without caveolae have very similar buoyant densities (15, 18), thereby
explaining the observed co-isolation of caveolae with GPI-anchored
protein microdomains (15). Interestingly, lipid anchoring of the
GPI-linked proteins and the dual acylated NRTK appear in both cases to
be critical for their existence in TIM (19, 20). Finally, it has become apparent that antibodies previously used to immunolocalize GPI-anchored proteins can actually cross-link them and artifactually induce sequestration into clusters associated with caveolae (21). Antibody sequestration of GPI-anchored proteins can induce cell surface signaling in cells without apparent caveolae leading to cell activation apparently via NRTK located in the same microdomains (22). Recently, another procedure for isolating caveolae has been developed using sonication in the absence of detergents to prepare vesicles that were
presented as being quite similar to TIM and enriched not only in
caveolin but also unfortunately GPI-anchored proteins (23). PDGF
receptors and other signaling molecules are also found in these later
vesicles (23, 24).
With this current knowledge, it is quite unclear where various
signaling mediators reside on the cell surface and what essential role,
if any, caveolae really play in signaling. Do all lipid-anchored proteins such as the NRTK partition on the cell surface similarly to
the GPI-anchored proteins? Or are NRTK unlike GPI-anchored proteins and
reside concentrated in caveolae? What about lipid signaling molecules
found enriched in the TIM? Do they reside in caveolae? And finally,
even if many of these molecules reside in caveolae, can it be
demonstrated more directly that distinct signal transduction really can
occur in caveolae? Here, we will try to address these questions by
utilizing both dual immunofluorescence confocal microscopy and a very
selective procedure for purifying caveolae separately from GPI-anchored
protein domains in order to define not only which, if any, signaling
molecules truly reside in caveolae but also regionalized signal
transduction possibly relegated to caveolae.
EXPERIMENTAL PROCEDURES
Materials
Reagents and other supplies were obtained from
the following sources: PDGF-BB (recombinant human PDGF) from R&D
Systems (Minneapolis, MN); VEGF (human) from Pepro Tech Inc. (Rochy
Hill, NJ); endothelin-1 from Sigma; protein
A-Sepharose from Pharmacia Biotech Inc.; [3H]choline
chloride (80 Ci/mmol) from DuPont NEN; [3H]inositol (80 Ci/mmol), donkey anti-rabbit IgG conjugated with HRP, sheep anti-mouse
IgG conjugated with HRP and the enhanced chemiluminescence (ECL)
detection kit from Amersham; and the bicinchoninic acid (BCA) protein
assay kit from Pierce.
Monoclonal antibodies to the following antigens were purchased from the
following vendors: caveolin (also polyclonal), PDGF -receptor,
phosphotyrosine, PKC , PKC , Fyn, Lck, and Lyn from Transduction
Laboratories (Lexington, KY); Src (monoclonal) from Oncogene Science
Inc. (Uniondale, NY); and PLC (monoclonal) from Upstate
Biotechnology Inc. (Lake Placid, NY). Polyclonal antibody to 85-kDa
subunit of PI 3-kinase was a kind gift from Dr. Lewis Cantley (Beth
Israel Hospital, Boston, MA), polyclonal antibody to c-Yes was a kind
gift from Dr. Marius Sudol (Rockefeller Institute, New York, NY). All
other reagents and supplies were obtained as in our past work (16, 25,
26).
Cell Culture
Rat lung microvascular endothelial cells
(RLMVEC) (a kind gift from Dr. Karen Guice, Duke University, Durham,
NC) were grown as described originally (27). MDCK cells were grown in
DMEM supplement with 10% fetal bovine serum as per ATCC
instructions.
Purification of Caveolae
As described previously (15),
caveolae were purified directly from luminal endothelial cell plasma
membranes isolated from rat lungs using an in situ
silica-coating procedure. Briefly, the rat lung vasculature was
perfused with a colloidal silica solution to coat selectively the
luminal surface of the endothelium in situ and allow
purification of the silica-coated endothelial cell plasma membrane (P)
from the tissue homogenate (H) by centrifugation. P was rich in
endothelial markers with little, if any, contamination from other
tissue components. The numerous caveolae attached to these membranes
were sheared off by homogenization in the presence or absence of 1%
Triton X-100 at 4 °C and then purified by sucrose gradient
flotation. A membrane band (V) was easily detected at a density of
15-20% sucrose and contained a homogeneous population of caveolae
amply enriched in caveolar markers with no detectable contamination
from other sources (15, 16). The resedimented pellet of silica-coated
membrane was devoid of caveolae (16) and was named P-V. In some
experiments, P-V along with 0.5-ml fractions were collected from the
top of sucrose gradient for lipid and protein analysis.
Isolation of Low Density TIM
The low buoyant density TIM
were obtained from MDCK cells as described previously (6). Similarly,
TIM were obtained from rat lungs by treating rat lung tissue with 1%
Triton as described originally (5) and in our past work (15).
Lipid Analysis
Sphingomyelin and phosphoinositides were
measured as described previously (28, 29). Briefly, perfused rat lungs
were incubated at 37 °C for 3 h in Kreb's solution containing
5% CO2/95% O2, and either
[3H]choline chloride (10 µCi/ml) or
[3H]inositol (15 µCi/ml). The lungs were processed for
isolation of caveolae or TIM (see above). Fractions (0.5 ml) were
collected from the sucrose gradients and 100 µl of each fraction was
placed into 10 × 130-mm glass tubes for lipid extraction using
chloroform/methanol/hydrochloric acid (1 N) (100:100:1).
The lower organic phase was collected and dried under N2.
For the detection of sphingomyelin, the lipid extract was subjected to
alkaline hydrolysis (1 N methanolic KOH at 37 °C for
1 h) to remove glycerophospholipids (29). Sphingomyelin or
phosphoinositides were then resolved by thin-layer chromatography using
chloroform/methanol/acetic acid/water at the ratio 50:30:8:4 or
55:43:3:4, respectively. The lipids were identified by iodine vapor
staining and quantified by liquid scintillation counter at an
efficiency of 48%. Phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate were identified by TLC initially assessing the lipid migration of tritium-labeled standards compared to
the migration of the lipids detected in the sample.
Protein Analysis
Proteins of cells and selected tissue
fractions were assessed and quantified by Western analysis as in our
past work (15, 16, 30). Briefly, they were solubilized with cold
solubilization buffer (SB) containing 0.17 M Tris-HCl (pH
6.8), 3% (w/v) SDS, 1.2% (v/v) -mercaptoethanol, 2 M
urea, and 3 mM EDTA in double-distilled water. After
incubation in boiling water for 4 min, they were separated by SDS-PAGE
(5-15% gels) and electrotransferred onto nitrocellulose filters for
immunoblotting using enhanced chemiluminescence autoradiography
followed by densitometric quantification using ImageQuant (Molecular
Dynamics). The protein concentration of the samples was measured using
the BCA method with bovine serum albumin as a standard.
Protein Phosphorylation Assay in Cultured Cells
RLMVEC were
incubated overnight in DMEM containing 1% fetal calf serum before
washing and treatment with DMEM containing PDGF (100 ng/ml),
endothelin-1 (100 nM), VEGF (10 ng/ml), or insulin (100 nM). The stimulation was terminated by adding SB in
preparation for SDS-PAGE and Western analysis to determine tyrosine
phosphorylation of proteins using a monoclonal antibody specific for
phosphotyrosines.
Immunoprecipitation
RLMVEC stimulated with PDGF (100 ng/ml,
10 min) were solubilized in lysis buffer (50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% Triton
X-100, 0.1% SDS, 1 mM Na3VO4, 10 µg/ml pepstatin A, 10 µg/ml leupeptin) on ice for 30 min. The cell
lysate was collected and spun at 5,000 rpm for 10 min in a
microcentrifuge to pellet cellular debris. The supernatant was
subjected to immunoprecipitation using an antibody specific for
phosphotyrosines, which was prebound to protein A-Sepharose beads.
After three washes with lysis buffer, the immunoprecipitated proteins
were solubilized in SB for Western analysis. To verify the specificity
of the antibody for phosphotyrosines, a parallel set of samples was
incubated in lysis buffer in the presence of 40 mM phenyl
phosphate.
Protein Phosphorylation Assay in Rat Lungs in Situ
The
pulmonary artery was perfused with: (i) Ringer's solution (5 mM HEPES (pH 7.4), 111 mM NaCl, 2.4 mM KCl, 1 mM MgSO4, 5.5 mM dextrose, 0.195 mM NaHCO3) at
room temperature to flush out the blood; (ii) Ringer's solution at
37 °C with or without 100 ng/ml of PDGF-BB for 3 min followed by 2 min of stasis; and (iii) Mes-buffered saline (MBS: 20 mM
Mes (pH 6), 125 mM NaCl) at 10 °C followed by the usual
series of solutions for the silica coating and purification of luminal
endothelial plasma membranes (see above) except that the HEPES perfused
just before tissue removal contained 1 mM
Na3VO4, 10 mM NaF. The lung tissue
was fractionated to purify the plasma membranes and caveolae as
described above. Tyrosine phosphorylation of proteins was determined by
Western analysis as above.
In Vitro Protein Kinase Assay
Protein kinase assay was
performed as described previously (31) on endothelial cell plasma
membrane fractions from rat lungs. Briefly, 3 µg of proteins each
from P, V, T, and P-V fractions were incubated with kinase buffer (25 mM HEPES (pH 7.4), 2.5 mM MgCl2, 0.5 mM MnCl2, 100 µM Na3VO4) in the presence or
absence of 100 µM ATP at room temperature for 10 min. The
assay was terminated by adding SB. All of each sample was loaded
for SDS-PAGE followed by Western analysis to determine protein-tyrosine
phosphorylation.
Immunofluorescence Microscopy
RLMVEC were treated as above
with or without 100 ng/ml PDGF at 37 °C for 10 min before performing
dual immunofluorescence as described in our past work (32). Briefly,
the RLMVEC were fixed with methanol at 20 °C for 10 min, blocked
with 2% goat serum, and stained with a mouse monoclonal antibody for
phosphotyrosine to detect tyrosine-phosphorylated proteins and/or a
rabbit polyclonal antibody against caveolin to detect caveolae. The
reporter IgG was conjugated with Bodipy (anti-rabbit IgG) and either
Texas Red or rhodamine (anti-mouse IgG). The immunofluorescence was visualized and photographed using a Zeiss Axio-phot microscope or a
confocal fluorescence microscope.
Confocal Microscopy
The cells (immunostained as above) were
sealed in the presence of Vectashield antifade and then examined using
a Sarastro 2000 confocal laser scanning microscope (Molecular Dynamics,
Sunnyvale, CA) fitted with a 25-milliwatt argon-ion laser. The
microscope was configured for dual channel fluorescent imaging with:
488/514 nm excitation, 535 nm primary beamsplitter, 10% laser
transmission, 18 milliwatt laser power. A 595 nm secondary beamsplitter
passed fluorescent light emitted from phosphotyrosine-labeled (Texas Red) vesicles to a photomultiplier tube fitted with a 600-nm-long pass
filter. Short wavelength light (<595 nm) emitted from the caveolin-labeled vesicles (Bodipy) was directed to a second
photomultiplier tube fitted with a 540 ± 15-nm band pass filter
and simultaneously recorded. Fields of adherent cells exhibiting a
crescent moon shape were brought into focus using a 60×/1.4 numeric
aperture PlanApo objective under bright field conditions and briefly
examined. A plane of focus 0.5 µm above the glass surface was
selected, and optical sections were then recorded under fluorescent
confocal microscopic conditions to reveal the distribution of
phosphotyrosines and caveolin-positive vesicles at the cell plasma
membrane. Image pairs were subjected to a two-dimensional median filter
to reduce background noise, then examined as color composite images
with the phosphotyrosine signal appearing red, and vesicles containing caveolin only green. Vesicles expressing both signals appeared yellow-orange.
Image Analysis
The distribution of phosphotyrosine and
caveolin was determined using quantitative image analysis procedure
(33-35) in which two-dimensional pixel intensity histograms from both
the phosphotyrosine and caveolin images were compared. Image analysis
was performed to determine the area occupied by
phosphotyrosine-containing vesicles, caveolin-labeled vesicles, and
those vesicles expressing both phosphotyrosine and caveolin. Pixel
dimensions of all micrographs were 0.08 or 0.17 µm, and the pixel
intensities ranged from 0 to 254 intensity units. The pixel intensity
range corresponding to the cell cytoplasm was determined separately for
each image. Cell background was found to be within a range of 4-29
pixel intensity units. The non-cellular background composed of
surrounding media and slide surface was determined to be 0-2 pixel
intensity units. Cells with fluorescent-stained phosphotyrosines were
observed to have pixel intensities from 20 to 254, whereas pixel
intensities for caveolin ranged between 30 and 254 units. To compare
the fluorochrome expression recorded in image pair, pixels
corresponding to phosphotyrosine or caveolin were applied to a
two-dimensional histogram of pixel intensities with phosphotyrosine
(x axis), plotted against caveolin (y axis), and
mapped as binary images on a pixel by pixel basis. Pixels unique to
each either phosphotyrosine or caveolin were identified on the
two-dimensional histogram and converted into a binary section. This
section was applied as a mask over the original image to produce area
measurements of vesicles on a per cell basis (35). This procedure was
repeatedly used to measure the area occupied by phosphotyrosine,
caveolin, and those vesicles expressing both fluorescent probes.
RESULTS
Here, we attempted to examine the potential role of caveolae in
compartmentalized signal transduction by utilizing two independent techniques: confocal immunofluorescence microscopy and plasmalemmal subfractionation analysis. A very selective subfractionation procedure was used for purifying caveolae from luminal plasma membranes of
endothelium isolated directly from tissue. As shown in our past work
(15, 16), this procedure, unlike various other methods (3-5, 9, 23),
avoided: (i) contamination from intracellular compartments by starting
with highly purified plasma membranes, (ii) potential artifacts induced
by isolating and growing cells in culture, and (iii) contamination from
other detergent-resistant microdomains including those rich in
cytoskeletal or GPI-anchored proteins. It did not require the use of
detergents. Briefly, the plasma membrane was coated with polycationic
colloidal silica particles so that a stable silica-coated membrane
pellicle of increased density was formed that allowed rapid effective
isolation to high purity by sedimentation. Equally important, the
silica particles uniformly coated the extracellular side of the plasma membrane opposite to the attached caveolae so that other noninvaginated microdomains including those rich in GPI-anchored proteins were firmly
adherent, thus preventing their detachment during the shear-mediated stripping and isolation of the caveolae (15, 16). This technique was
used in situ by intravascular perfusion to allow the
purification directly from tissue of endothelial cell caveolae to
homogeneity with significant enrichment in known caveolar markers (15,
16). It clearly separates caveolae from GPI-anchored protein domains. Here, we first established that these purified caveolae were indeed rich in various key signaling molecules including, surprisingly, certain lipid and lipid-anchored molecules previously not detected in
the TIM because of their detergent solubility. Next, we show that a
specific ligand can initiate signaling selectively in caveolae as
detected by protein-tyrosine phosphorylation regionalized in caveolae
and that this signal cascade is inhibited when caveolae are
disrupted.
Lipid Analysis
We first examined the effects of Triton X-100
on two kinds of lipid signaling molecules, sphingomyelin (SM) and
phosphoinositides, in cell membranes in general. Rat lungs were
prelabeled with either [3H]choline or
[3H]inositol before homogenizing the rat lung tissue. The
homogenates were treated with Triton X-100 and subjected to sucrose
density centrifugation to isolate a visible band of low density TIM
floating at 15-20% sucrose (fractions 4-6). Lipid analysis revealed
that TIM contained abundant [3H]sphingomyelin, but very
little, if any, [3H]phosphatidylinositol (PI). As shown
in Fig. 1A, approximately 50% of
sphingomyelin in rat lung homogenate was found in TIM with 30% in
Triton-soluble phase (T) (T1-T5) and 20% in pellet. When normalized
by protein concentration (to allow a meaningful comparison of
approximately equal amounts of membrane), SM was enriched 20-fold in
TIM over starting homogenate (H) (Fig. 1B). By comparison, little PI was found in TIM (<5% of H). The major portion of PI was
found in the Triton-soluble phase, which accounted for 71% of H. Consistent with our past results (15), immunoblotting showed that
caveolin was enriched 3-5-fold in the TIM relative to H and it was
distributed similarly to SM in the fractions collected from the sucrose
gradients (data not shown). Our results were consistent with a previous
report that SM, but not PI (<5%), was concentrated in the TIM
isolated from cultured MDCK cells (6). When we used MDCK cells (see
"Experimental Procedures"), we found about 60% of SM was recovered
in TIM, with 20% each in the Triton-soluble phase and the pellet (data
not shown). For PI >95% was in the Triton-soluble phase. These
results confirm that TIM are rich in SM but not PI. In contrast to
these findings, a recent study (7) shows PI in TIM at levels varying
from about 10 to 25%. This discrepancy may be explained by
methodological differences such as the use of a 40 to 5% sucrose
step-gradient in Ref. 7, rather than a 40 to 5% continuous gradient,
which may improve separation.
Fig. 1.
Analysis of sphingomyelin and
phosphoinositides in TIM and purified caveolae. Sphingomyelin
(filled bars) and phosphatidylinositol (hatched
bars) were radiolabeled in situ in the intact rat lung before tissue subfractionation. The lipids were extracted and analyzed
in the starting lung homogenate (H), TIM, purified
silica-coated luminal endothelial cell plasma membranes (P),
caveolae purified either in the presence (V) or absence
(V ) of Triton X-100, Triton-soluble phase either as single
fractions (T1-T5) or combined (T), 40% sucrose
fraction (S ), or resedimented silica-coated plasma
membranes stripped of caveolae (P-V or P-V ). TIM
were isolated from rat lungs (A and B) and
caveolae were purified from P in the presence (C and
D) or absence (E) of Triton X-100. When Triton
was present, sphingomyelin but not phosphoinositides was found
concentrated in TIM (B) and caveolae (D). Without
Triton X-100 (E), both phosphoinositides and sphingomyelin
were found highly enriched in the purified caveolae (V ). In
F, the phosphoinositides in V were subjected to Triton X-100 solubilization. The lipid radioactivity detected in each fraction
collected after centrifugation of the sucrose gradient is shown in
A, C, and F, while B,
D, and E show the data from the pertinent
combined fractions with the detected radioactivity normalized to
protein content as a measure of assessing relative enrichments. Each
graph depicts the data of one representative experiment from three
(A, B, E, and F) or five
(C and D) experiments with similar
findings.
[View Larger Version of this Image (32K GIF file)]
To investigate whether SM is truly concentrated in caveolae, the lipid
components were analyzed in highly purified caveolae. Rat lungs were
radiolabeled as above with tritiated precursors and then processed for
purification of the silica-coated luminal endothelial cell plasma
membranes (P) and then the caveolae (V). As reported previously (15,
16, 30), Western analysis showed that the purified caveolae were rich
in caveolin with a 12-fold enrichment of caveolin in V over P (data not
shown). Very little caveolin (about 3% of P) remained in P-V (the
repelleted silica-coated plasma membranes after removing the caveolae).
Lipid analysis showed that the major peak signal of
[3H]SM radioactivity was recovered in the purified
caveolae fractions. Fig. 1C shows the distribution of SM in
each fraction of sucrose gradient. The amount of SM in fractions 4-5
(V) and P-V was approximately equal for each at 35-40% of P. Fig.
1D shows the signal for SM normalized to the protein content
of the collected fractions. The enrichment of SM in caveolae (V) was
10-fold relative to P and 23-fold over P-V. In contrast to SM, PI was
found mostly in the Triton-soluble phase (T1-T5), which accounted for
86% of P. Very little PI was detected in caveolae (approximately 2%
of P). These results indicate that SM was concentrated in the caveolae of the plasma membrane.
It is known that phospholipids including PI can be extracted from cell
membranes by Triton X-100 (10, 36). To avoid this detergent effect, we
also purified caveolae in the absence of Triton X-100. Fig.
1E shows that caveolae purified without detergent were
indeed rich in PI. The lipid signal in caveolae fraction (V ) was
enriched by 5-7-fold over both P and P-V . Phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate were also found
enriched in purified caveolae (data not shown) along with caveolin as
reported previously (15). By comparison, there was very little PI found
in Triton-free 40% sucrose phase (S ) (approximately 2% of P). As
expected, the signal for SM was enriched in V , which was 11-fold more
than P-V (Fig. 1E).
To verify the Triton X-100 solubility of the caveolar PI, the
radiolabeled purified caveolae were treated with cold Triton X-100 for
10 min before sucrose gradient centrifugation. Fig. 1F shows
the analysis of PI in each fraction of the gradient. Clearly, the
Triton X-100 extracted PI with the majority being recovered in
detergent-soluble phases (T1-T5), which accounted for 65% of total
radioactivity. Hence, our lipid analysis shows that two types of key
lipid signaling molecules, SM and PI, can both reside concentrated in
caveolae.
NRTK Reside Concentrated in Caveolae
Many past studies report
NRTK are enriched in TIM in some cases with GPI-anchored proteins (5,
8, 19). This association for both types of proteins requires lipid
anchoring (8, 19, 20) and can be found in cells that lack caveolae (17,
18). It remains unclear whether NRTK are present in caveolae not
concentrated in GPI-anchored proteins. Thus, we performed Western
analysis on the rat lung tissue subfractions to attempt to detect Yes, Fyn, Lck, Lyn, and Src using monospecific antibodies. All of these NRTK
were detected in the silica-coated luminal endothelial cell plasma
membranes at levels quite enriched over the starting lung homogenate
(Fig. 2). Because our preparations are not contaminated with blood cell components including lymphocytes, as assessed by
immunoblotting for specific blood cell
markers2 and based on the apparent
monospecificity of the antibodies (no cross-reaction with Syk, ZAP 70, Src and Fyn),3 it appears that the
endothelium expressed several different NRTK on its cell surface
including Lck. Also the distinct differences in band pattern and Triton
solubility (see below) for each of the NRTK suggested that the
antibodies recognized different proteins and were not cross-reactive
within this group of NRTK.
Fig. 2.
Analysis of NRTK in purified caveolae.
Proteins (5 µg) from the rat lung homogenate (H),
silica-coated endothelial plasma membranes (P), purified
endothelial caveolae (V or V ), Triton soluble
fraction (T), and silica-coated plasma membranes stripped of
caveolae (P-V or P-V ) were subjected to SDS-PAGE and Western analysis with antibodies specific for Yes, Fyn, Lck, Lyn,
and Src. Left panel shows data for subfractionation
performed in the presence of Triton X-100, while the right
panel is in the absence of the detergent.
[View Larger Version of this Image (32K GIF file)]
The caveolae purified in the presence of Triton X-100 showed that many
of the NRTK were significantly solubilized by the detergent (Fig. 2).
Yes and Lyn were the most resistant to solubilization and were easily
detected in V. Lck and Fyn were detected in V but were primarily found
in the Triton-soluble fraction (T). Only a very weak signal for Src was
detected in V with much of Src being solubilized by the Triton X-100.
Little of the NRTK remained behind in P-V except for Src, which,
therefore, appeared to reside in a noncaveolar domain that was
resistant, at least in part, to detergent extraction.
When caveolae were purified in the absence of Triton X-100, all of
these NRTK were found in the detergent-free purified caveolae (V ) at
levels much greater than the plasma membrane stripped of the caveolae
(P-V ) (Fig. 2). Table I shows the relative enrichment and percent distribution of these proteins in the plasma membranes and
its subcomponents. On the endothelial cell surface, much of Lck, Fyn,
Lyn, and Yes resided concentrated in caveolae. Src also was detected
concentrated in caveolae but to a lesser extent. Src was present
significantly in other noncaveolar plasmalemmal domains remaining in
P-V . Immunofluorescence microscopy confirmed the presence of Yes, Lck,
Lyn, and Src in endothelial cells and their caveolae by showing
significant co-localization of these NRTK with caveolin on the surface
of cultured lung endothelial cells (data not shown). Unfortunately, the
antibody to Fyn did not detect its antigens in this assay. Thus, it
appears that unlike GPI-anchored proteins, various NRTK reside on the
endothelial cell surface concentrated in caveolae.
Table I.
Enrichment and total recovery of signaling molecules detected in
endothelial cell caveolae
The enrichment of each signaling protein in caveolae isolated with
(PDGF, PI 3-kinase, PLC , PKC and ) or without (Yes, Fyn, Lck,
Lyn, and Src) Triton X-100 was obtained by Western blotting as shown in
Figs. 2 and 3A. The total recovery of each protein in
caveolae isolated without Triton (V ) was estimated by enzyme-linked immunosorbent assay of each fraction from the sucrose gradient as shown
in Fig. 3B. In this assay, V were fractions of 5-12, while
P-V was the membrane pellet after removing the caveolae. As shown
clearly in the examples given in Fig. 3B, the remainder of
the signal was distributed over the other 20 fractions at much smaller
levels ranging from 0 to nearly 4% of the signal.
| Proteins |
Enrichment (V/P-V) |
% of total in P1
|
V |
P-V |
|
| Caveolin |
20 |
60.8 |
1.93
|
| PDGF-R |
5.7 |
46.6 |
12.9
|
| PI3-kinase |
7.22 |
51.0 |
13.4
|
PLC |
9.15 |
51.6 |
11.4
|
PKC |
16.5 |
NAa |
NA
|
PKC |
19 |
35.7 |
13.6
|
| Yes |
9.5 |
NA |
NA
|
| Fyn |
5.5 |
36.5 |
3.37 |
| Lck |
8.48 |
34.2 |
4.68
|
| Lyn |
7.0 |
40.4 |
8.81 |
| Src |
5.38 |
23.5 |
10.2 |
|
|
a
NA, not available.
|
|
Other Signaling Molecules Found in Caveolae
We also have
screened the endothelial caveolae purified from rat lung for the
presence of other key signaling molecules. So far, we have found PDGF
-receptor, PI 3-kinase, PLC , and PKC and isoforms amply
expressed on the silica-coated luminal endothelial cell plasma
membranes and in their caveolae (Fig. 3A).
Enzyme-linked immunosorbent assays were performed on the sucrose
gradient (Fig. 3B) to quantify the relative distribution of
these molecules (Table I). Notably, many of the targets of the PDGF
receptor tyrosine kinase including PI 3-kinase, PLC , and NRTK (37)
were in the caveolae (Figs. 2 and 3A). By comparison, SHC
and Ras-GAP were not found enriched in caveolae (data not shown). As
expected, various kinases more downstream in the signaling pathway such
as ERK1 and ERK2 were not detected in the purified plasma membrane with
caveolae (data not shown). As reported previously (14, 15, 28),
caveolin, but not -actin and 5 -nucleotidase, was highly enriched in
these purified caveolae (Fig. 3A).
Fig. 3.
Distribution of PKC, PDGF receptor, and its
substrates in the plasmalemmal and its caveolae. A, as
described in Fig. 2, rat lungs were subfractionated and H,
P, V, T, and P-V were immunoblotted for the indicated proteins. B, distribution of
caveolin, PDGF receptor, and PI 3-kinase in sucrose gradient used to
purify caveolae from P. Each fraction (150 µl) was collected from the top of the sucrose gradient, and proteins were detected by
enzyme-linked immunosorbent assay as described previously (15, 16)
using antibodies against the antigens as shown. Data are expressed as a
percentage of total signal detected in all the fractions from P.
[View Larger Version of this Image (27K GIF file)]
Ligand-induced Signal Transduction Localized within
Caveolae
Although we have shown that various key signaling
molecules were found in caveolae, the necessary functional evidence for signal transduction in caveolae has been lacking. It is possible that
caveolae might not transduce signals directly across the membrane into
the cell and alternatively could function as some sort of storage or
recovery site for signaling molecules. Therefore, in order to
investigate whether signal transduction could occur specifically and
directly in caveolae, we tested a panel of ligands (endothelin-1, PDGF,
insulin, or VEGF) known to activate various signaling pathways in
endothelium. These ligands bind to their respective receptors to
transduce a signal into the cell through processes involving at least
in part some of the molecules that we have found in caveolae (note we
have shown previously that G proteins can be found but not enriched in
the purified endothelial caveolae; Ref. 30). Using RLMVEC, we
immunodetected tyrosine phosphorylation of proteins in response to
these ligands with the phosphorylation pattern differing significantly
among these ligands (Fig. 4). PDGF clearly provided the
strongest signal. This finding was confirmed by immunofluorescence
microscopy. Extensive tyrosine phosphorylation was visualized on the
surface of the PDGF-stimulated cells but not the unstimulated cells
(Fig. 5). With PDGF stimulation, abundant small but
strong punctate labeling was easily observed at the cell surface and
leading edge of the cell, which is consistent with phosphorylation
events not randomly distributed over the cell surface but rather
localized in discrete small patches that could be vesicular in nature.
The signal detected for the cells treated with the other ligands was
much less (consistent with our immunoblots), and this signal was not
detected in control experiments performed without primary antibody
(data not shown). From these experiments, it was quite clear that PDGF
caused the more extensive rapid tyrosine phosphorylation of proteins in
this system, and therefore we focused for the remainder of this study on PDGF.
Fig. 4.
Protein-tyrosine phosphorylation in response
to ET-1, PDGF, insulin, and VEGF. As described under
"Experimental Procedures," RLMVEC were incubated with DMEM alone
for 10 min (control) or with 100 nM endothelin-1
(ET-1) for 5 min or with 100 ng/ml PDGF, 100 nM
insulin, or 10 ng/ml VEGF for 10 min. Cellular proteins were
solubilized and subjected to SDS-PAGE and Western analysis with a
monoclonal antibody recognizing phosphotyrosine.
[View Larger Version of this Image (64K GIF file)]
Fig. 5.
Immunofluorescence microscopy of PDGF-induced
tyrosine phosphorylation. RLMVEC were incubated for 10 min with
DMEM alone (A and B) or with 5 µg/ml filipin
(C) and then for 10 min with DMEM alone (A) or
with 100 ng/ml PDGF (B and C). Tyrosine phosphorylation was detected by immunofluorescence microscopy using the
phosphotyrosine-specific antibody. Bar indicates 20 µm.
[View Larger Version of this Image (54K GIF file)]
Before trying to localize the cell surface signaling, we first further
characterized the PDGF-induced protein phosphorylation. Fig.
6 shows that the PDGF-induced tyrosine phosphorylation
was time- and concentration-dependent. It increased rather
linearly to reach an apparent maximum at about 10-15 min and then
decreased afterward (Fig. 6, A and B).
PDGF-induced protein phosphorylation was easily detectable at 10 ng/ml,
while a PDGF concentration of 100 ng/ml seemed to give a maximal
response (Fig. 6, C and D). Treatment of RLMVEC
with PDGF phosphorylated several proteins with apparent molecular
masses of 180-200, 120, 85, 60, and 40 kDa (Fig. 6, A and
F). Immunoprecipitation with antibody to phosphotyrosine followed by immunoblotting revealed that PDGF -receptor and PI 3-kinase (85-kDa subunit) were among the phosphorylated proteins (data
not shown). Pretreatment of these cells with a specific tyrosine kinase
inhibitor, genistein, or less-specific inhibitor, staurosporine,
substantially inhibited PDGF-induced protein-tyrosine phosphorylation,
suggesting that protein phosphorylation observed resulted from a
tyrosine kinase activity induced by PDGF (Fig. 6E).
Preincubation of the cells with staurosporine alone also reduced
tyrosine phosphorylation signal, suggesting a basal tyrosine kinase
activity in these cells.
Fig. 6.
Characterization of tyrosine phosphorylation
induced by PDGF. RLMVEC were treated with 100 ng/ml PDGF for the
indicated time (A) or with the indicated concentration of
PDGF for 10 min (C). Total cellular protein (20 µg in each
lane) was subjected to SDS-PAGE and Western analysis with the
phosphotyrosine antibody. Total tyrosine phosphorylation in
A and C was quantified densitometrically, and
these data are presented graphically in B and D,
respectively. In E, RLMVEC were incubated with or without
100 ng/ml PDGF in the presence or absence of genistein or staurosporine
as indicated. In F, RLMVEC were treated with (lanes
2, 5, and 6) or without (lanes 1,
3, and 4) 100 ng/ml PDGF and the
tyrosine-phosphorylated proteins were immunoprecipitated with the
phosphotyrosine-specific antibody in the presence (lanes 4 and 6) or absence (lanes 3 and 5) of
40 mM phenyl phosphate. The starting cell lysate
(lanes 1 and 2) and immunoprecipitated proteins
(lanes 3-6) were subjected to SDS-PAGE and Western analysis
with phosphotyrosine antibody. Arrows indicate proteins
being phosphorylated by PDGF (see "Results").
[View Larger Version of this Image (38K GIF file)]
Next, we utilized confocal immunofluorescence microscopy to ascertain
whether PDGF caused signal transduction specifically within caveolae
located on the surface of cultured endothelial cells. Fig.
7 shows that double immunostaining for phosphotyrosines and caveolin in the PDGF-stimulated RLMVEC revealed extensive co-localization at the cell surface. Tyrosine-phosphorylated proteins were detected in cell surface structures that also labeled with caveolin. Image analysis, in which two-dimensional pixel intensity histograms from both the phosphotyrosine and caveolin images were compared, allowed quantification of overlapping signals (see
"Experimental Procedures"). Pixels with signal from phosphotyrosine
or caveolin were identified using high stringency criteria and
converted into a binary section to produce area measurements of the
regions occupied by phosphotyrosine, caveolin, or both signals. Fig. 7
shows a representative image. By quantifying the cell surface signal in 0.5-µm optical sections of 20 different cells in this detailed manner, we found an average of 82.4 ± 13.3% (with a median of 90) of the phosphotyrosine signal to be co-localized in
caveolin-containing caveolae at the cell surface. Interestingly, only
59.8 ± 26.0% of the caveolae detected at the plasma membrane
with the caveolin antibodies exhibited detectable tyrosine
phosphorylation. This latter finding suggested the presence of
significant caveolar subpopulations: one induced to signal and the
other not induced by PDGF. It was interesting to note that, unlike the
first colocalization category, a rather large variation was observed in
the latter, which ranged from a low of 10% to high of 90% overlap of
the caveolin-containing structures also exhibiting phosphotyrosine
signal. Thus, the caveolar subpopulations probably are distributed in
patches rather than uniformly over the cell surface. At least in
cultured cells, regions with a high density of caveolae tend to be
interspersed with long stretches of plasmalemma having few caveolae
(38).2 These findings indicate that PDGF-induced signaling
as detected by protein-tyrosine phosphorylation can indeed occur
directly in caveolae.
Fig. 7.
Co-localization of PDGF-induced
protein-tyrosine phosphorylation with caveolin. Original confocal
micrographs (a-c) of RLMVEC following PDGF stimulation.
Bar = 5 µm. Panel a, phosphotyrosine expression on membrane surfaces are apparent. Panel b,
caveolae distribution as revealed by caveolin labeling shows punctate
staining at the cell surface. A composite image (c)
resulting from the superimposition of a and b
reveals significant co-localization of caveolin staining with the
phosphotyrosine signal induced by PDGF (yellow/orange).
Enlarged micrographs (d-f) from the box in
a show vesicles expressing phosphotyrosine (d),
caveolin (e), and vesicles with both phosphotyrosine and
caveolin (f) following two-dimensional colocalization
analysis in which pixel intensities and their precise location were
mapped and superimposed over the original micrographs.
Yellow/orange punctate signal represents vesicles where both
phosphotyrosine and caveolin are present (f). Quantitative
image analysis revealed vesicles containing phosphotyrosine (d) occupied 8.45 µm2, vesicles containing
caveolin (e) were found to occupy 8.31 µm2,
and those vesicles containing both phosphotyrosine and caveolin (f) occupied 7.36 µm2. Bar = 1 µm.
[View Larger Version of this Image (108K GIF file)]
Isolating and growing cells in culture might induce extensive
phenotypic drift, easily detected at the morphological level, for
instance, in endothelial cells by a significant reduction in the
surface density of caveolae (38). Therefore, it was imperative that our
in vitro findings be tested on endothelium in tissue in vivo. We examined possible signaling in endothelium under
more native conditions by Western blotting using the
phosphotyrosine-specific antibody to assess the tyrosine
phosphorylation of endothelial plasmalemmal and caveolar proteins in
response to PDGF administered in situ. We perfused rat lungs
with and without PDGF and then performed our usual subfractionation
procedure using the silica-coating method. Fig.
8A shows that under base-line conditions,
little tyrosine phosphorylation was detected in the whole lung
homogenates (H) or its subfractions (P, T, or P-V) with the possible
exception of two proteins of about 50 and 52 kDa detected most clearly
in the purified caveolae (consistent with their apparent significant enrichment in caveolae). Perfusion of PDGF dramatically increased the
phosphorylation detected in all of the fractions. PDGF induced the
tyrosine phosphorylation of multiple proteins easily detected as seven
bands by Western analysis of P. There was a considerable increase in
the detected signal in P over H as would be expected for a cell
surface-mediated event. All seven phosphorylated plasma membrane
proteins were found primarily in the purified caveolae (V), with little
remaining behind in the plasma membrane stripped of caveolae (P-V).
Very little, if any, signal was detected in either T or P-V. In
addition to the seven bands, several phosphorylated proteins were
detected in V but not in P, which is consistent with a significant
overall enrichment of the proteins phosphorylated by PDGF. Finally, we
were able to immunoprecipitate the phosphotyrosine-containing vesicles
from V and find abundant caveolin in them, thereby providing further
assurance that the caveolae did indeed contain the proteins phosphorylated by PDGF (Fig. 8B). It would appear that the
signaling as detected by the PDGF-induced phosphorylation occurred
selectively and directly in the caveolae. These observations were quite
consistent with the confocal immunofluorescence image analysis. Both
techniques demonstrated that PDGF initiated signaling events transduced
specifically in caveolae.
Fig. 8.
PDGF-induced protein-tyrosine phosphorylation
in endothelial caveolae of rat lungs in situ. A,
rat lungs were perfused in situ for 5 min with or without
(control) PDGF at 37 °C before tissue subfractionation.
Western analysis of tyrosine-phosphorylated proteins (5 µg/lane for
H, P, T, and P-V except that 2.5 µg/lane for V) is shown.
Arrows indicate the tyrosine-phosphorylated proteins induced
by PDGF in P and even more so in V. B,
caveolae purified from PDGF-stimulated rat lungs as above were
immunoprecipitated in the presence or absence of 40 mM
phenyl phosphate using Dynabeads-conjugated phosphotyrosine antibody as
described previously (30). The resulting supernatant (S) and
immunoprecipitated vesicles (IP) were subjected to SDS-PAGE
and immunoblotted with the antibody for caveolin.
[View Larger Version of this Image (69K GIF file)]
Purified Caveolae Rich in Tyrosine Kinase Activity
To test
further caveolar function in signaling and examined whether caveolae
have endogenous kinase activity when separated from other plasma
domains, the silica-coated rat lung endothelial plasma membranes were
subfractionated and the basal tyrosine kinase activity of the important
fractions was examined in vitro. Consistent with the
observations described above, there was very little base-line tyrosine
phosphorylation detected in the fractions in the absence of ATP (Fig.
9). By comparison, tyrosine phosphorylation was
significantly increased in P in the presence of ATP, suggesting
endothelial plasma membrane possesses intrinsic tyrosine kinase
activity. Notably, most of the protein-tyrosine phosphorylation
occurred in the caveolae, which was detected as a 30-fold enrichment of overall phosphorylation in V relative to P or P-V. Little to no tyrosine phosphorylation was detected in T. Several phosphorylated proteins with molecular masses of 180, 140, 36-40, and 18-20 kDa, which were not readily detected in P and P-V, were found in caveolae. Hence, these results indicate that tyrosine kinase(s) and their substrates are both quite concentrated in caveolae. In contrast to the
PDGF-induced tyrosine phosphorylation, the intrinsic basal kinase(s) in
this assay recognized a different subset of proteins (compare Figs.
8A and 9). The proteins phosphorylated with PDGF stimulation
had molecular masses of 180-200, 120, 85, and 48-50 kDa, whereas
proteins with molecular masses of 85-116, 48-50, 36-40, and 18-23
kDa were the preferred substrates for the intrinsic kinase(s). More
specifically, caveolin was one of the major proteins being
phosphorylated in caveolae by this in vitro kinase assay, whereas very little phosphorylation of caveolin was detected by in situ stimulation with PDGF.
Fig. 9.
Intrinsic tyrosine kinase activity of plasma
membrane predominantly found in caveolae. Subfractions of
silica-coated endothelial plasma membranes from rat lungs (P, V, T, and
P-V) were obtained and equal protein aliquots from each fraction were incubated with kinase buffer in the presence (+) or absence ( ) of 100 µM ATP. Tyrosine phosphorylation was detected by Western analysis.
[View Larger Version of this Image (48K GIF file)]
Disassembly of Caveolae Prevents Propagation of PDGF-induced
Signaling Cascade
If caveolae are cell surface microdomains
concentrating protein kinases and their substrates and if this
compartmentalization is important in signaling, then the loss of the
caveolar subcomponent of the plasma membrane may prevent efficient
access of kinases to their substrates and thereby abrogate or even
interrupt the signaling cascade of the activated PDGF receptor. We have
shown previously that filipin, which is a polyene antibiotic that binds and removes cholesterol from membrane, reversibly causes disassembly of
caveolae resulting in dispersion of caveolar proteins over the
endothelial cell surface (25). Using filipin concentrations causing
more than a 75% decrease in the endothelial cell surface density of
caveolae (25), we treated RLMVEC first with filipin before stimulation
with PDGF. The effects of filipin first were examined by
immunofluorescence microscopy. Filipin caused a striking change in the
immunofluorescence staining pattern for protein-tyrosine phosphorylation induced by PDGF. The substantial phosphorylation induced by PDGF was evident in the untreated control cells by the
strong punctate signal on the surface and leading edge of the cells
(Fig. 5B). With filipin treatment, the fluorescence-detected phosphorylation signal weakened significantly, became much less organized and punctate on the cell surface, and was much more diffusely
distributed over the cell surface (Fig. 5C). This rather diffuse staining pattern was consistent with a much less organized or
regionalized protein-tyrosine phosphorylation at the cell surface.
In agreement with these findings, we also found by immunofluorescence
that PDGF receptors clustered to give a punctate staining pattern on
the cell surface, which was dispersed to a diffuse pattern with filipin
treatment of the cells. Unfortunately, this antibody, like most
antibodies to growth factors, was not monospecific. It recognized by
Western analysis not only the 180-kDa PDGF receptor band but also other
protein bands. Thus, definitive interpretation of the
immunofluorescence microscopy results was not possible (data not
shown).
Detection of tyrosine phosphorylation by Western analysis showed more
directly that filipin substantially reduced the PDGF-stimulated tyrosine phosphorylation of proteins (Fig. 10,
A and B). Little phosphorylation was detected
with filipin pretreatment. Only the PDGF receptor appeared to be
phosphorylated, which was also much less than the control. Both 2 and 5 µg/ml filipin were effective with the latter being a bit more
inhibitory. When we used vanadate to stimulate tyrosine phosphorylation
as a control, filipin did not reduce the phosphorylation (Fig.
10B). In fact, surprisingly there was a moderate increase,
which might be caused by the redistribution of kinases, phosphatases,
and their substrates. Although there is no indication that filipin is a
general tyrosine kinase inhibitor, we still tested it along with
staurosporine in our in vitro kinase assay using V. Tyrosine
phosphorylation of proteins was not diminished by filipin but was
almost eliminated by staurosporine (Fig. 10C). The
disruption by filipin of the caveolae as an organized subcompartment of
the plasmalemma appeared to prevent the PDGF-induced signal from
efficiently and rapidly propagating past the autophosphorylation of its
receptor, to downstream targets necessary for the robust protein-tyrosine phosphorylation normally seen in the endothelial cells. Without proper subcompartmentalization, the usual PDGF-signaling cascade was interrupted.
Fig. 10.
Inhibition of the PDGF receptor signaling
cascade by filipin. Tyrosine phosphorylation of proteins was
detected by Western analysis. A, RLMVEC were pretreated for
10 min with DMEM in the presence or absence of 2 or 5 µg/ml filipin
and then incubated with 100 ng/ml PDGF for 10 min before SDS-PAGE and
immunoblotting. B, as in A, RLMVEC were
pretreated with 5 µg/ml filipin as indicated and then stimulated for
10 min with either PDGF or vanadate (100 µM).
C, filipin is not an intrinsic kinase inhibitor like
staurosporine. Caveolae purified from rat lungs were divided equally
into four parts to perform our in vitro kinase assay. Before
incubation with 100 µM ATP, aliquots were pretreated with
Hepes buffer alone or with 5 µg/ml filipin (10 min) or 5 µM staurosporine (5 min).
[View Larger Version of this Image (25K GIF file)]
DISCUSSION
TIM, Caveolae, and Lipid-anchored Proteins
Here, we focus on
one specific type of TIM, namely the caveolae, which we have separated
distinctly from a number of other possible Triton-insoluble
microdomains including, but probably not limited to, those on the cell
surface rich in GPI-anchored proteins or cytoskeletal elements along
with those inside the cell such as the trans-Golgi exocytic vesicles
rich in glycolipids, caveolin, and GPI-anchored proteins (15). Not
surprisingly, these other noncaveolar domains can be found in cells
apparently with few or no caveolae using the standard TIM isolation
procedure (6, 17, 18). The caveolae purification procedure used here is
the only one to date that inherently prevents co-isolation of other
noncaveolar domains that are physically very similar to caveolae in
their detergent resistance and buoyant densities (15). Thus, these two
physical criteria when used for isolating caveolae (3, 4, 39) cannot
inherently separate such similar domains. Another procedure for
isolating caveolae has been proposed very recently, with similar
results to the TIM, because again unfortunately only two
nondiscriminating criteria are used for separation: buoyant density,
coupled in this case with membrane disruption by sonication rather than
detergent treatment (23). It is the actual coating of the plasma
membrane with the silica particles that provides two additional
separation criteria to the purification procedures: (i) it allows
isolation to high purity of the pertinent starting material, namely the
plasma membranes, thereby avoiding contamination from other sources;
and (ii) it stably attaches to the plasmalemma proper, thereby
preventing excision of the flat noninvaginated domains, which can be
detergent-resistant, are rich in GPI-anchored proteins or cytoskeletal
elements, and are not by definition the invaginated caveolar
microdomains (15-18).
A potential disadvantage of the silica-coating method for purifying
caveolae includes the possibility that the mobile GPI-anchored proteins
may move from the caveolae and bind to the silica particles. In a
recent paper (40), we have shown that GPI-anchored proteins are not
present in caveolae that bud from plasma membranes and instead remained
behind with the plasmalemma proper. Interestingly, the budding of
caveolin-rich vesicles lacking GPI-anchored proteins has been detected
using not only the purified silica-coated plasma membranes but also
plasma membranes not coated with silica and isolated on a Percoll
gradient. Thus, it is not the silica-coating that specifically
contributes to the lack of GPI-anchored proteins observed in our highly
purified caveolae. Furthermore, immuno-electron microscopy shows that
GPI-anchored proteins are not actually in the caveolae isolated using
the Triton methodology (no silica present) but rather are located in
the larger vesicles contaminating this preparation (15).
The silica-coating technique is quite effective in purifying caveolae
in the absence of detergents (15, 16). Detergent-free purification can
be quite important in light of the increasing number of caveolar
molecules that, at least in part, can be extracted from the caveolae by
Triton X-100 and therefore may in some cases be poorly detected or even
absent in isolated TIM. If so, then at least some of the molecules
solubilized into the detergent phase may be originally from the
caveolae. Caveolin, which appears to polymerize around the bulb of the
caveolae (41, 42), is quite resistant to detergent extraction at low
temperatures, but that does not mean that all caveolar molecules need
be the same, especially lipids and lipid-anchored proteins. We have
found in this study that this is indeed true. Although sphingomyelin is quite resistant to Triton extraction and enriched in both TIM and
purified caveolae, we have found that phosphoinositides, which reside
concentrated in caveolae, are easily extracted from plasma membranes
and the purified caveolae. To a lesser extent, the same is true for the
Src-like kinases, which exhibit a wide range of sensitivity to Triton
solubilization and yet they can be found in caveolae to varying
degrees. On the cell surface, Yes, Lck, and, to a lesser extent, Fyn
and Lyn seem to reside mostly in caveolae. Src is also found in
caveolae but in addition appears to reside elsewhere in a
detergent-resistant noncaveolar microdomain of the plasma membrane.
Some of the distributional diversity of the Src-like kinases in the
plasmalemma may relate to differences in their lipid anchoring, especially dual acylation and direct interactions with other more firmly entrenched detergent-resistant caveolar proteins. It has been
reported that G proteins, which also are dual acylated and present not
only in TIM (3, 4) but also in purified caveolae (30), can interact
with caveolin itself (43). Interestingly, G proteins can exist in TIM
regardless of whether they are isolated from cells with or without
caveolae (3, 4, 44). They can be immunoprecipitated with GPI-anchored
proteins and most probably can also reside in the small GPI-anchored
protein microdomains (44). These findings are consistent with the
concept that the binding to caveolin and the local lipid milieu causing
detergent resistance contribute independently to the preferential
partitioning of these molecules into these distinct microdomains. Could
it be that caveolin or even other detergent-resistant resident proteins of caveolae provide the anchoring necessary to keep some, but not
other, lipid-anchored proteins selectively in caveolae over other
microdomains when present? It will be interesting to determine why
nature has created this distinction. Recently, eNOS, another dually
acylated protein, has been shown to reside on the endothelial cell
surface in caveolae (45).
Our previous results have demonstrated that the glycosphingolipid,
GM1, is concentrated in caveolae (15). Caveolae are likely to be very rich in cholesterol, which binds to caveolin (46). In fact,
removal of cholesterol from the plasma membrane causes caveolae to
disassemble, resulting in significantly reduced endocytosis or
transcytosis of select macromolecules (25). Cumulatively, these results
are consistent with the hypothesis that the lipid composition in
caveolae differs significantly from the plasmalemma proper and may be
quite important in their function.
Signaling Molecules in Caveolae
Two major classes of lipid
mediators of cell surface signaling are the phosphoinositides and
sphingomyelin. Sphingomyelin is a minor lipid component involved in the
regulation of cell growth and proliferation. Cytokines such as tumor
necrosis factor- and interleukin-1 bind to their respective
receptors and stimulate the hydrolysis of sphingomyelin to generate the
second messenger ceramide which activates a ceramide-activated protein
kinase (31). Our finding of enrichment of sphingomyelin in purified
caveolae demonstrates the topology of this lipid signal molecule in
plasma membranes, although its function there remains unclear. Recent studies using normal human fibroblasts show that interleukin 1 stimulates ceramide and diacylglycerol production primarily in sphingomyelin-rich TIM (47).
Phosphoinositides are essential signaling molecules mediating several
receptor transduction pathways, including G-protein coupled receptor
and tyrosine kinase receptor pathways (48). Ligand-activated receptors
stimulate PLC to hydrolyze phosphatidylinositol 4,5-bisphosphate to
generate two second messengers: diacylglycerol, which activates PKC,
and inositol 1,4,5-trisphosphate (IP3), which binds to an
IP3 receptor to mobilize stored Ca2+ and
promote an influx of external Ca2+ (48, 49). Interestingly,
caveolae purified from endothelium possess the
IP3-sensitive channel and Ca2+ ATPase (16),
suggesting that caveolae play an important role in the regulation of
intracellular calcium levels. Consistent with a role for caveolae in
signaling, caveolae also are quite enriched in other signaling
molecules found in the plasma membranes including PDGF -receptor,
PKC, PI 3-kinase, and PLC . Caveolae appear to be rich in the lipid
precursors and proteins necessary for regionalized signal transduction
for several different signaling pathways.
Caveolae as Signaling Subcompartments of the Plasma
Membrane
The concept of signaling compartments within the cell
has evolved into a current theme in signal transduction and is well supported by selective subcellular distribution of many signaling molecules (1). The observed promiscuity of kinases, especially in
reconstituted assays, suggests that the intermolecular mechanisms for
specificity are not absolute and that another level of organization may
be required for more specific directed vectorial signaling. Compartmentalization creates appropriate access to the necessary substrates for initiation of the pertinent regionalized cascade reaction. Intracellular localization creating the suitable molecular proximity may be required to achieve fully the specificity necessary for balancing downstream pathway diversity with selectivity in effects
and responses. Elements of various signaling pathways including
G-proteins and many protein kinases and phosphatases have been shown to
be compartmentalized intracellularly, for instance at the nucleus,
plasma membrane, or Golgi (1, 50, 51).
In this study, we have extended this concept of signaling compartments
by further dissecting the plasmalemmal compartment into
subcompartments. Using both new subfractionation techniques and
confocal immunofluorescence image analysis, we provide compelling direct evidence for signal transduction at the plasma membrane subcompartmentalized in caveolae. As discussed above, many key signaling molecules found at the cell surface actually appear to reside
clustered in caveolae. Many other laboratories have also shown
signaling molecules in various membrane subfractions such as TIM (3, 4,
6, 8, 9). Although these findings support the hypothesis that caveolae
function as specific microdomains on cell surface in compartmentalized
signal transduction, they do not directly demonstrate functionality. To
test this hypothesis more directly, we choose to examine ligand-induced
protein phosphorylation in endothelium found both in tissue in
situ and grown in culture. PDGF induces protein-tyrosine
phosphorylation on the luminal endothelial cell surface rather
selectively, if not exclusively, in the purified caveolae. The PDGF
receptor located in caveolae is quickly autophosphorylated by its
ligand. The proteins, which are phosphorylated rapidly in response to
PDGF, are also found in the caveolae. Many known targets of the PDGF
receptor tyrosine kinase including PI 3-kinase, PLC , Src, Yes, and
Fyn (37) are found in the purified caveolae. Our PDGF-related findings
agree substantially with a very recent study (24) that showed PDGF
receptors and associated signaling molecules in a caveolar preparation
that, although isolated without detergent, was characterized by the
investigators to be similar to TIM including, unfortunately, its
enrichment in GPI-linked proteins (23). Thus, it appears that the PDGF
signaling cascade does indeed reside in the caveolae and is not being
detected in our preparations because of the presence of what may be
associated but clearly distinct GPI-anchored proteins domains (15).
Moreover, our immuno-affinity isolations provide direct evidence that
the tyrosine-phosphorylated proteins are present in the same
vesicles containing caveolin (Fig. 8B).
The localization of these signaling molecules within a small
invaginated microdomain is likely to provide the proximity necessary for rapid, efficient, and specific propagation of the transduced kinase
activity to immediate nearby substrates that appropriately promote
downstream signaling events. Consistent with this concept, PDGF
signaling was halted at the level of autophosphorylation of its
receptor and was not capable of propagating the signal efficiently to
the usual downstream targets when the caveolae with their organized
subset of plasmalemmal signaling molecules were disrupted. Filipin
treatment of the cells reversibly causes a very significant loss of
caveolae at the endothelial cell surface and results in the dispersion
of proteins normally found in caveolae (25). Without the properly
organized caveolar subcompartment, the PDGF signaling cascade was
interrupted. Finally, we have found that caveolae have both significant
intrinsic tyrosine kinase activity and multiple different kinase
substrates. Our in vitro kinase assay using purified plasma
membranes and caveolae reveals that caveolae have intrinsic kinase
activity so that other plasmalemmal components are not required for
tyrosine phosphorylation. In fact, most of the intrinsic kinase
activity of the plasmalemmal compartment is derived from the caveolar
subcompartment. The proteins phosphorylated in vitro are
different from those induced by PDGF, indicating that PDGF initiates a
specific cascade by only phosphorylating a subset of potential
substrates in caveolae. Thus, the evidence to date supports the
existence of caveolae as organized subcompartments of the plasmalemma
functioning in signal transduction.
Cells seeming to lack caveolin expression and apparent caveolae on
their cell surface, such as lymphocytes, appear fully functional in
responding to growth factors and in all aspects of cell growth and
signaling. Interestingly, these cells have microdomains resistant to
Triton X-100 solubilization that can be isolated similarly to caveolae
as low density membranes in a sucrose gradient. These TIM are rich in
Src-like kinases and GPI-anchored proteins, which when cross-linked
with antibodies cluster on the cell surface and induce signaling events
(17, 18, 22). Thus, not surprisingly, it appears that caveolae are not
the only type of plasmalemmal subcompartment organized to transduce
specific signaling cascades. More work will be needed to provide the
distinctions necessary to resolve why two distinct microdomains have
evolved with what may be similar functions.
Relationship of Signaling to Caveolar Function in
Transport
It is thought that caveolae may also function in
transport via fluid-phase and receptor-mediated endocytosis and
transcytosis (for review, see Ref. 52). The debate in this area has
centered on whether caveolae are dynamic vesicular carriers capable of budding, docking, and fusion like other transport vesicles or rather
permanent static structures of the plasmalemma. It could be argued
that the latter is more apt to be the case at least for caveolae that
function in signal transduction; however, transport of the caveolar
signaling subcompartment into the cell may provide an important
regulatory function that eliminates, augments, or otherwise changes
signaling, possibly by targeting specific intracellular compartments.
Recently, our laboratory has shown that caveolae have the molecular
machinery necessary for transport via vesicular budding, docking, and
fusion (26, 30). More importantly, they can bud directly from the
plasma membrane via a fission process requiring GTP hydrolysis
(40).
If signaling caveolae can be internalized, then caveolae may function
not only in compartmentalized signal transduction but also in a broader
sense as complete signaling processing centers. Maybe specific
signaling events are required to initiate caveolar budding and
transport. It will be important in the future to assess the possible
interrelationship between signaling and transport by determining
whether, and if so how, caveolae integrate signal transduction with
their ability to function as dynamic carrier organelles. As signaling
processing centers, caveolae organize signaling molecules to provide a
topographic compartment at the cell surface that may determine
substrate specificity and ultimately define the signaling pathway,
message and even cellular response. In turn, caveolae may regulate cell
surface signaling by escorting the signaling molecules into the cell to
sustain, consume or otherwise change its effect.
FOOTNOTES
*
This work was reported in part at the ASCB Annual Meeting in
Washington, D.C. (Dec., 1995) and ASBMB/ASIP Joint Meeting in New
Orleans (June, 1996) (FASEB J., 10, A998, 1996). This work
was supported by NIH grant HL52766 (to J. E. S.) and was done during
the tenure of an Established Investigator Award from the Am. Heart
Assoc. and Genentech (to J. E. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Pathology,
Harvard Medical School, Research North-Beth Israel, 330 Brookline Ave.,
Boston, MA 02215. Tel.: 617-667-3577; Fax: 617-667-3591; E-mail:
jschnitz{at}bidmc.harvard.edu.
1
The abbreviations used are: TIM,
Triton-insoluble membrane(s); MDCK, Madin-Darby canine kidney; GPI,
glycosylphosphatidylinositol; PDGF, platelet-derived growth factor;
NRTK, nonreceptor tyrosine kinase; PKC, protein kinase C; Mes,
2-(N-morpholino)ethanesulfonic acid; VEGF, vascular
endothelial growth factor; PI 3-kinase, phosphatidylinositol 3-kinase;
PI, phosphatidylinositol; PLC, phospholipase C; PAGE, polyacrylamide
gel electrophoresis; DMEM, Dulbecco's modified Eagle's medium;
IP3, inositol 1,4,5-trisphosphate; RLMVEC, rat lung
microvascular endothelial cell(s); SM, sphingomyelin; P, plasma
membrane; H, homogenate; T, Triton-soluble phase; V, vesicle.
2
P. Oh, D. P. McIntosh, and J. E. Schnitzer, unpublished observations.
3
R. Campos, personal communication.
Acknowledgments
We thank Dr. Lewis Cantley for reviewing this
manuscript and generously providing the PI 3-kinase antibody, Dr.
Marius Sudol for generously providing the c-Yes antibody, and Dr. Karen
Guice for generously providing RLMVEC.
REFERENCES
-
Mochly-Rosen, D.
(1995)
Science
268,
247-251
[Abstract/Free Full Text]
-
Strosberg, A. D.
(1991)
Eur. J. Biochem.
196,
1-10
[Medline]
[Order article via Infotrieve]
-
Sargiacomo, M., Sudol, M., Tang, Z., and Lisanti, M. P.
(1993)
J. Cell Biol.
122,
789-807
[Abstract/Free Full Text]
-
Chang, W.-J., Ying, Y., Rothberg, K. G., Hooper, N. M., Turner, A. J., Gambliel, H. A., De Gunzburg, J., Mumby, S. M., Gilman, A. G., and Anderson, R. G. W.
(1994)
J. Cell Biol.
126,
127-138
[Abstract/Free Full Text]
-
Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y. H., Cook, R. F., and Sargiacomo, M.
(1994)
J. Cell Biol.
126,
111-126
[Abstract/Free Full Text]
-
Brown, D. A., and Rose, J. K.
(1992)
Cell
68,
533-544
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hope, H. R., and Pike, L. J.
(1996)
Mol. Biol. Cell
7,
843-851
[Abstract]
-
Arreaza, G., Melkonian, K. A., LaFevre-Bernt, M., and Brown, D. A.
(1994)
J. Biol. Chem.
269,
19123-19127
[Abstract/Free Full Text]
-
Smart, E. J., Ying, Y. S., and Anderson, R. G.
(1995)
J. Cell Biol.
131,
929-938
[Abstract/Free Full Text]
-
Yu, J., Fischman, D. A., and Steck, T. L.
(1973)
J. Supramol. Struct.
1,
233-248
[CrossRef][Medline]
[Order article via Infotrieve]
-
Fox, J. E., Reynolds, C. C., and Boyles, J. K.
(1992)
Methods Enzymol.
215,
42-58
[Medline]
[Order article via Infotrieve]
-
Anderson, R. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
10909-10913
[Abstract/Free Full Text]
-
Lisanti, M. P., Scherer, P. E., Tang, Z., and Sargiacomo, M.
(1994)
Trends Cell Biol.
4,
231-235
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dupree, P., Parton, R. G., Raposo, G., Kurzchalia, T. V., and Simons, K.
(1993)
EMBO J.
12,
1597-1605
[Medline]
[Order article via Infotrieve]
-
Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J., and Oh, P.
(1995)
Science
269,
1435-1439
[Abstract/Free Full Text]
-
Schnitzer, J. E., Oh, P., Jacobson, B. S., and Dvorak, A. M.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
1759-1763
[Abstract/Free Full Text]
-
Fra, A. M., Williamson, E., Simons, K., and Parton, R. G.
(1994)
J. Biol. Chem.
269,
30745-30748
[Abstract/Free Full Text]
-
Gorodinsky, A., and Harris, D. A.
(1995)
J. Cell Biol.
129,
619-627
[Abstract/Free Full Text]
-
Rodgers, W., Crise, B., and Rose, J. K.
(1994)
Mol. Cell. Biol.
14,
5384-5391
[Abstract/Free Full Text]
-
Shenoy-Scaria, A. M., Dietzen, D. J., Kwong, J., Link, D. C., and Lublin, D. M.
(1994)
J. Cell Biol.
126,
353-363
[Abstract/Free Full Text]
-
Mayor, S., Rothberg, K. G., and Maxfield, F. R.
(1994)
Science
264,
1948-1951
[Abstract/Free Full Text]
-
Stefanova, I., Horejsi, V., Ansotegui, I. J., Knapp, W., and Stockinger, H.
(1991)
Science
254,
1016-1019
[Abstract/Free Full Text]
-
Smart, E. J., Ying, Y. S., Mineo, C., and Anderson, R. G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10104-10108
[Abstract/Free Full Text]
-
Liu, P., Ying, Y., Ko, Y.-G., and Anderson, R. G. W.
(1996)
J. Biol. Chem.
271,
10299-10303
[Abstract/Free Full Text]
-
Schnitzer, J. E., Oh, P., Pinney, E., and Allard, J.
(1994)
J. Cell Biol.
127,
1217-1232
[Abstract/Free Full Text]
-
Schnitzer, J. E., Allard, J., and Oh, P.
(1995)
Am. J. Physiol.
268,
H48-H55
[Abstract/Free Full Text]
-
Magee, J. C., Stone, A. E., Oldham, K. T., and Guice, K. S.
(1994)
Am. J. Physiol.
267,
L433-L441
[Abstract/Free Full Text]
-
Medh, J. D., and Weigel, P. H.
(1989)
J. Lipid Res.
30,
761-764
[Abstract]
-
Dressler, K. A., Mathias, S., and Kolesnick, R. N.
(1992)
Science
255,
1715-1718
[Abstract/Free Full Text]
-
Schnitzer, J. E., Liu, J., and Oh, P.
(1995)
J. Biol. Chem.
270,
14399-14404
[Abstract/Free Full Text]
-
Liu, J., Mathias, S., Yang, Z., and Kolesnick, R. N.
(1994)
J. Biol. Chem.
269,
3047-3052
[Abstract/Free Full Text]
-
Schnitzer, J. E., and Oh, P.
(1996)
Am. J. Physiol.
270,
H416-H422
[Abstract/Free Full Text]
-
Rogers, R. A., Jack, R. M., and Furlong, S. T.
(1993)
J. Cell Sci.
106,
485-492
[Abstract]
-
Li, J., Avraham, H., Rogers, R. A., and Avraham, S.
(1996)
Blood
88,
417-428
[Abstract/Free Full Text]
-
Masahiko, S., Jackman, R. M., Donselaar, E., Behar, S. M., Rogers, R. A., Peters, P. J., Brenner, M. B., and Porcelli, S. A.
(1996)
Science
273,
349-352
[Abstract]
-
Schroeder, R., London, E., and Brown, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12130-12134
[Abstract/Free Full Text]
-
Kazlauskas, A.
(1994)
Curr. Opin. Genet. Dev.
4,
5-14
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schnitzer, J. E., Siflinger-Birnboim, A., Del Vecchio, P. J., and Malik, A. B.
(1994)
Biochem. Biophys. Res. Commun.
199,
11-19
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lisanti, M. P., Scherer, P. E., Tang, Z., and Sargiacomo, M.
(1995)
Methods Enzymol.
250,
655-668
[Medline]
[Order article via Infotrieve]
-
Schnitzer, J. E., McIntosh, D. P., and Oh, P.
(1996)
Science
274,
239-242
[Abstract/Free Full Text]
; Erratum (1996) Science 274, 1069
-
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y. S., Glenney, J. R., and Anderson, R. G.
(1992)
Cell
68,
673-682
[CrossRef][Medline]
[Order article via Infotrieve]
-
Monier, S., Parton, R. G., Vogel, F., Behlke, J., Henske, A., and Kurzchalia, T. V.
(1995)
Mol. Biol. Cell
6,
911-927
[Abstract]
-
Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., and Lisanti, M. P.
(1995)
J. Biol. Chem.
270,
15693-15701
[Abstract/Free Full Text]
-
Solomon, K. R., Rudd, C. E., and Finberg, R. W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
95,
6053-6058
-
Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J. E., and Sessa, W. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6448-6453
[Abstract/Free Full Text]
-
Murata, M., Peranen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., and Simons, K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10339-10343
[Abstract/Free Full Text]
-
Liu, P., and Anderson, R. G. W.
(1995)
J. Biol. Chem.
270,
27179-27185
[Abstract/Free Full Text]
-
Berridge, M. J.
(1993)
Nature
361,
315-325
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nishizuka, Y.
(1988)
Nature
334,
661-665
[CrossRef][Medline]
[Order article via Infotrieve]
-
Inglese, J., Freedman, N. J., Koch, W. J., and Lefkowitz, R. J.
(1993)
J. Biol. Chem.
268,
23735-23738
[Free Full Text]
-
Pawson, T.
(1995)
Nature
373,
573-580
[CrossRef][Medline]
[Order article via Infotrieve]
-
Schnitzer, J. E.
(1993)
Trends Cardiovasc. Med.
3,
124-130
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D.-A. Persaud-Sawin, S. Lightcap, and G. J. Harry
Isolation of rafts from mouse brain tissue by a detergent-free method
J. Lipid Res.,
April 1, 2009;
50(4):
759 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Awasthi, S. K. Mandal, V. Papanna, L. V. M. Rao, and U. R. Pendurthi
Modulation of Tissue Factor-Factor VIIa Signaling by Lipid Rafts and Caveolae
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2007;
27(6):
1447 - 1455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-H. Sun, D. C. Flynn, V. Castranova, L. L. Millecchia, A. R. Beardsley, and J. Liu
Identification of a Novel Domain at the N Terminus of Caveolin-1 That Controls Rear Polarization of the Protein and Caveolae Formation
J. Biol. Chem.,
March 9, 2007;
282(10):
7232 - 7241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. John, B. O. Ibe, and J. Usha Raj
Oxygen alters caveolin-1 and nitric oxide synthase-3 functions in ovine fetal and neonatal lung microvascular endothelial cells
Am J Physiol Lung Cell Mol Physiol,
November 1, 2006;
291(5):
L1079 - L1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yang, T. N. Oo, and V. Rizzo
Lipid rafts mediate H2O2 prosurvival effects in cultured endothelial cells
FASEB J,
July 1, 2006;
20(9):
1501 - 1503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. M. Wang, H. P. Kim, R. Song, and A. M. K. Choi
Caveolin-1 Confers Antiinflammatory Effects in Murine Macrophages via the MKK3/p38 MAPK Pathway
Am. J. Respir. Cell Mol. Biol.,
April 1, 2006;
34(4):
434 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Park, M. Suh, B. Thomson, A. B.R. Thomson, K. S. Ramanujam, and M. T. Clinin
Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains
Glycobiology,
October 1, 2005;
15(10):
935 - 942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Veluthakal, I. Chvyrkova, M. Tannous, P. McDonald, R. Amin, T. Hadden, D. C. Thurmond, M. J. Quon, and A. Kowluru
Essential Role for Membrane Lipid Rafts in Interleukin-1{beta}-Induced Nitric Oxide Release From Insulin-Secreting Cells: Potential Regulation by Caveolin-1+
Diabetes,
September 1, 2005;
54(9):
2576 - 2585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. G. Hill, E. Almasri, W. G. Ruiz, G. Apodaca, and M. L. Zeidel
Water and solute permeability of rat lung caveolae: high permeabilities explained by acyl chain unsaturation
Am J Physiol Cell Physiol,
July 1, 2005;
289(1):
C33 - C41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tkachenko, J. M. Rhodes, and M. Simons
Syndecans: New Kids on the Signaling Block
Circ. Res.,
March 18, 2005;
96(5):
488 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Williams and M. P. Lisanti
Caveolin-1 in oncogenic transformation, cancer, and metastasis
Am J Physiol Cell Physiol,
March 1, 2005;
288(3):
C494 - C506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Beardsley, K. Fang, H. Mertz, V. Castranova, S. Friend, and J. Liu
Loss of Caveolin-1 Polarity Impedes Endothelial Cell Polarization and Directional Movement
J. Biol. Chem.,
February 4, 2005;
280(5):
3541 - 3547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Cohen, R. Hnasko, W. Schubert, and M. P. Lisanti
Role of Caveolae and Caveolins in Health and Disease
Physiol Rev,
October 1, 2004;
84(4):
1341 - 1379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Czarny and J. E. Schnitzer
Neutral sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium
Am J Physiol Heart Circ Physiol,
September 1, 2004;
287(3):
H1344 - H1352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ono, Y. Iwanaga, M. Hirayama, T. Kawamura, N. Sowa, and K. Hasegawa
Contribution of caveolin-1{alpha} and Akt to TNF-{alpha}-induced cell death
Am J Physiol Lung Cell Mol Physiol,
July 1, 2004;
287(1):
L201 - L209.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Gratton, P. Bernatchez, and W. C. Sessa
Caveolae and Caveolins in the Cardiovascular System
Circ. Res.,
June 11, 2004;
94(11):
1408 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Y. Y. Tam, K. W. Finnson, and A. Philip
Glycosylphosphatidylinositol-anchored Proteins Regulate Transforming Growth Factor-{beta} Signaling in Human Keratinocytes
J. Biol. Chem.,
December 5, 2003;
278(49):
49610 - 49617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Carver, J. E. Schnitzer, R. G. W. Anderson, and S. Mohla
Role of Caveolae and Lipid Rafts in Cancer: Workshop Summary and Future Needs
Cancer Res.,
October 15, 2003;
63(20):
6571 - 6574.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rizzo, C. Morton, N. DePaola, J. E. Schnitzer, and P. F. Davies
Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro
Am J Physiol Heart Circ Physiol,
October 1, 2003;
285(4):
H1720 - H1729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Thorn, K. G. Stenkula, M. Karlsson, U. Ortegren, F. H. Nystrom, J. Gustavsson, and P. Stralfors
Cell Surface Orifices of Caveolae and Localization of Caveolin to the Necks of Caveolae in Adipocytes
Mol. Biol. Cell,
October 1, 2003;
14(10):
3967 - 3976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Frank, S. E. Woodman, D. S. Park, and M. P. Lisanti
Caveolin, Caveolae, and Endothelial Cell Function
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2003;
23(7):
1161 - 1168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shack, X.-T. Wang, G. C. Kokkonen, M. Gorospe, D. L. Longo, and N. J. Holbrook
Caveolin-Induced Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Increases Arsenite Cytotoxicity
Mol. Cell. Biol.,
April 1, 2003;
23(7):
2407 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Czarny, J. Liu, P. Oh, and J. E. Schnitzer
Transient Mechanoactivation of Neutral Sphingomyelinase in Caveolae to Generate Ceramide
J. Biol. Chem.,
February 7, 2003;
278(7):
4424 - 4430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Razandi, A. Pedram, S. T. Park, and E. R. Levin
Proximal Events in Signaling by Plasma Membrane Estrogen Receptors
J. Biol. Chem.,
January 17, 2003;
278(4):
2701 - 2712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nanjundan and F. Possmayer
Pulmonary phosphatidic acid phosphatase and lipid phosphate phosphohydrolase
Am J Physiol Lung Cell Mol Physiol,
January 1, 2003;
284(1):
L1 - L23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lee, D. S. Park, X. B. Wang, P. E. Scherer, P. E. Schwartz, and M. P. Lisanti
Src-induced Phosphorylation of Caveolin-2 on Tyrosine 19. PHOSPHO-CAVEOLIN-2 (TYR(P)19) IS LOCALIZED NEAR FOCAL ADHESIONS, REMAINS ASSOCIATED WITH LIPID RAFTS/CAVEOLAE, BUT NO LONGER FORMS A HIGH MOLECULAR MASS HETERO-OLIGOMER WITH CAVEOLIN-1
J. Biol. Chem.,
September 6, 2002;
277(37):
34556 - 34567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Razani, S. E. Woodman, and M. P. Lisanti
Caveolae: From Cell Biology to Animal Physiology
Pharmacol. Rev.,
September 1, 2002;
54(3):
431 - 467.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Boucher, P. Liu, M. Gotthardt, T. Hiesberger, R. G. W. Anderson, and J. Herz
Platelet-derived Growth Factor Mediates Tyrosine Phosphorylation of the Cytoplasmic Domain of the Low Density Lipoprotein Receptor-related Protein in Caveolae
J. Biol. Chem.,
May 3, 2002;
277(18):
15507 - 15513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Garver, K. Krishnan, J. R. Gallagos, M. Michikawa, G. A. Francis, and R. A. Heidenreich
Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae
J. Lipid Res.,
April 1, 2002;
43(4):
579 - 589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhuang, J. Lin, M. L. Lu, K. R. Solomon, and M. R. Freeman
Cholesterol-rich Lipid Rafts Mediate Akt-regulated Survival in Prostate Cancer Cells
Cancer Res.,
April 1, 2002;
62(8):
2227 - 2231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Razandi, P. Oh, A. Pedram, J. Schnitzer, and E. R. Levin
ERs Associate with and Regulate the Production of Caveolin: Implications for Signaling and Cellular Actions
Mol. Endocrinol.,
January 1, 2002;
16(1):
100 - 115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A.O. Stuermer, D. M. Lang, F. Kirsch, M. Wiechers, S.-O. Deininger, and H. Plattner
Glycosylphosphatidyl Inositol-anchored Proteins and fyn Kinase Assemble in Noncaveolar Plasma Membrane Microdomains Defined by Reggie-1 and -2
Mol. Biol. Cell,
October 1, 2001;
12(10):
3031 - 3045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ros-Baro, C. Lopez-Iglesias, S. Peiro, D. Bellido, M. Palacin, A. Zorzano, and M. Camps
Lipid rafts are required for GLUT4 internalization in adipose cells
PNAS,
September 26, 2001;
(2001)
211341698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Trouet, I. Carton, D. Hermans, G. Droogmans, B. Nilius, and J. Eggermont
Inhibition of VRAC by c-Src tyrosine kinase targeted to caveolae is mediated by the Src homology domains
Am J Physiol Cell Physiol,
July 1, 2001;
281(1):
C248 - C256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Young, Y. Ikeda, and A. M. Lefer
Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism
Am J Physiol Heart Circ Physiol,
June 1, 2001;
280(6):
H2489 - H2495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, P. Lee, F. Galbiati, R. N. Kitsis, and M. P. Lisanti
Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation
Am J Physiol Cell Physiol,
April 1, 2001;
280(4):
C823 - C835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-A. Impagnatiello, S. Weitzer, G. Gannon, A. Compagni, M. Cotten, and G. Christofori
Mammalian Sprouty-1 and -2 Are Membrane-anchored Phosphoprotein Inhibitors of Growth Factor Signaling in Endothelial Cells
J. Cell Biol.,
March 5, 2001;
152(5):
1087 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Krawczyk and J. M. Penninger
Molecular motors involved in T cell receptor clusterings
J. Leukoc. Biol.,
March 1, 2001;
69(3):
317 - 330.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Oh and J. E. Schnitzer
Segregation of Heterotrimeric G Proteins in Cell Surface Microdomains. Gq Binds Caveolin to Concentrate in Caveolae, whereas Gi and Gs Target Lipid Rafts by Default
Mol. Biol. Cell,
March 1, 2001;
12(3):
685 - 698.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Govers and T. J. Rabelink
Cellular regulation of endothelial nitric oxide synthase
Am J Physiol Renal Physiol,
February 1, 2001;
280(2):
F193 - F206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lee, D. Volonte, F. Galbiati, P. Iyengar, D. M. Lublin, D. B. Bregman, M. T. Wilson, R. Campos-Gonzalez Boumediene Bouzahzah, R. G. Pestell, P. E. Scherer, et al.
Constitutive and Growth Factor-Regulated Phosphorylation of Caveolin-1 Occurs at the Same Site (Tyr-14) in Vivo: Identification of a c-Src/Cav-1/Grb7 Signaling Cassette
Mol. Endocrinol.,
November 1, 2000;
14(11):
1750 - 1775.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Yu, J. Cassara, and P. F. Weller
Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells
Blood,
February 1, 2000;
95(3):
1078 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Miotti, M Bagnoli, A Tomassetti, M. Colnaghi, and S Canevari
Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1
J. Cell Sci.,
January 1, 2000;
113(2):
349 - 357.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-s. Huang, J. Zhou, A. K. Feng, C. C. Lynch, J. Klumperman, S. J. DeArmond, and W. C. Mobley
Nerve Growth Factor Signaling in Caveolae-like Domains at the Plasma Membrane
J. Biol. Chem.,
December 17, 1999;
274(51):
36707 - 36714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Smart, G. A. Graf, M. A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Mol. Cell. Biol.,
November 1, 1999;
19(11):
7289 - 7304.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Citores, J. Wesche, E. Kolpakova, and S. Olsnes
Uptake and Intracellular Transport of Acidic Fibroblast Growth Factor: Evidence for Free and Cytoskeleton-anchored Fibroblast Growth Factor Receptors
Mol. Biol. Cell,
November 1, 1999;
10(11):
3835 - 3848.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Simons, T. Friedrichson, J. B. Schulz, M. Pitto, M. Masserini, and T. V. Kurzchalia
Exogenous Administration of Gangliosides Displaces GPI-anchored Proteins from Lipid Microdomains in Living Cells
Mol. Biol. Cell,
October 1, 1999;
10(10):
3187 - 3196.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Oh and J. E. Schnitzer
Immunoisolation of Caveolae with High Affinity Antibody Binding to the Oligomeric Caveolin Cage. TOWARD UNDERSTANDING THE BASIS OF PURIFICATION
J. Biol. Chem.,
August 13, 1999;
274(33):
23144 - 23154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Soltysik-Espanola, R. A. Rogers, S. Jiang, T.-A. Kim, R. Gaedigk, R. A. White, H. Avraham, and S. Avraham
Characterization of Mayven, a Novel Actin-binding Protein Predominantly Expressed in Brain
Mol. Biol. Cell,
July 1, 1999;
10(7):
2361 - 2375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y.-G. Ko, J.-S. Lee, Y.-S. Kang, J.-H. Ahn, and J.-S. Seo
TNF-{alpha}-Mediated Apoptosis Is Initiated in Caveolae-Like Domains
J. Immunol.,
June 15, 1999;
162(12):
7217 - 7223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, B. Razani, S. Tang, B. I. Terman, J. A. Ware, and M. P. Lisanti
Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells. ANGIOGENESIS INHIBITORS BLOCK VASCULAR ENDOTHELIAL GROWTH FACTOR-INDUCED DOWN-REGULATION OF CAVEOLIN-1
J. Biol. Chem.,
May 28, 1999;
274(22):
15781 - 15785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Parolini, S. Topa, M. Sorice, A. Pace, P. Ceddia, E. Montesoro, A. Pavan, M. P. Lisanti, C. Peschle, and M. Sargiacomo
Phorbol Ester-induced Disruption of the CD4-Lck Complex Occurs within a Detergent-resistant Microdomain of the Plasma Membrane. INVOLVEMENT OF THE TRANSLOCATION OF ACTIVATED PROTEIN KINASE C ISOFORMS
J. Biol. Chem.,
May 14, 1999;
274(20):
14176 - 14187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. O. Rybin, X. Xu, and S. F. Steinberg
Activated Protein Kinase C Isoforms Target to Cardiomyocyte Caveolae : Stimulation of Local Protein Phosphorylation
Circ. Res.,
May 14, 1999;
84(9):
980 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Volonte, F. Galbiati, S. Li, K. Nishiyama, T. Okamoto, and M. P. Lisanti
Flotillins/Cavatellins Are Differentially Expressed in Cells and Tissues and Form a Hetero-oligomeric Complex with Caveolins in Vivo. CHARACTERIZATION AND EPITOPE-MAPPING OF A NOVEL FLOTILLIN-1 MONOCLONAL ANTIBODY PROBE
J. Biol. Chem.,
April 30, 1999;
274(18):
12702 - 12709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ilangumaran, S. Arni, G. van Echten-Deckert, B. Borisch, and D. C. Hoessli
Microdomain-dependent Regulation of Lck and Fyn Protein-Tyrosine Kinases in T Lymphocyte Plasma Membranes
Mol. Biol. Cell,
April 1, 1999;
10(4):
891 - 905.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Czarny, Y. Lavie, G. Fiucci, and M. Liscovitch
Localization of Phospholipase D in Detergent-insoluble, Caveolin-rich Membrane Domains. MODULATION BY CAVEOLIN-1 EXPRESSION AND CAVEOLIN-182-101
J. Biol. Chem.,
January 29, 1999;
274(5):
2717 - 2724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Bilderback, V.-R. Gazula, M. P. Lisanti, and R. T. Dobrowsky
Caveolin Interacts with Trk A and p75NTR and Regulates Neurotrophin Signaling Pathways
J. Biol. Chem.,
January 1, 1999;
274(1):
257 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rizzo, D. P. McIntosh, P. Oh, and J. E. Schnitzer
In Situ Flow Activates Endothelial Nitric Oxide Synthase in Luminal Caveolae of Endothelium with Rapid Caveolin Dissociation and Calmodulin Association
J. Biol. Chem.,
December 25, 1998;
273(52):
34724 - 34729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Park, Y.-M. Go, P. L. St. John, M. C. Maland, M. P. Lisanti, D. R. Abrahamson, and H. Jo
Plasma Membrane Cholesterol Is a Key Molecule in Shear Stress-dependent Activation of Extracellular Signal-regulated Kinase
J. Biol. Chem.,
November 27, 1998;
273(48):
32304 - 32311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Krisch, J. Feindt, and R. Mentlein
Immunoelectronmicroscopic Analysis of the Ligand-induced Internalization of the Somatostatin Receptor Subtype 2 in Cultured Human Glioma Cells
J. Histochem. Cytochem.,
November 1, 1998;
46(11):
1233 - 1242.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. W. Shaul and R. G. W. Anderson
Role of plasmalemmal caveolae in signal transduction
Am J Physiol Lung Cell Mol Physiol,
November 1, 1998;
275(5):
L843 - L851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rizzo, A. Sung, P. Oh, and J. E. Schnitzer
Rapid Mechanotransduction in Situ at the Luminal Cell Surface of Vascular Endothelium and Its Caveolae
J. Biol. Chem.,
October 9, 1998;
273(41):
26323 - 26329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamamoto, Y. Toya, C. Schwencke, M. P. Lisanti, M. G. Myers Jr., and Y. Ishikawa
Caveolin Is an Activator of Insulin Receptor Signaling
J. Biol. Chem.,
October 9, 1998;
273(41):
26962 - 26968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Field, E. Born, S. Murthy, and S. N. Mathur
Caveolin is present in intestinal cells: role in cholesterol trafficking?
J. Lipid Res.,
October 1, 1998;
39(10):
1938 - 1950.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Cusinato, W. Habeler, F. Calderazzo, F. Nardi, and A. Bruni
Loss of phosphoserine polar group asymmetry and inhibition of cholesterol transport in Jurkat cells treated with cholesterylphosphoserine
J. Lipid Res.,
September 1, 1998;
39(9):
1844 - 1851.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. J. Pike and J. M. Miller
Cholesterol Depletion Delocalizes Phosphatidylinositol Bisphosphate and Inhibits Hormone-stimulated Phosphatidylinositol Turnover
J. Biol. Chem.,
August 28, 1998;
273(35):
22298 - 22304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Kifor, R. Diaz, R. Butters, I. Kifor, and E. M. Brown
The Calcium-sensing Receptor Is Localized in Caveolin-rich Plasma Membrane Domains of Bovine Parathyroid Cells
J. Biol. Chem.,
August 21, 1998;
273(34):
21708 - 21713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Engelman, R. J. Lee, A. Karnezis, D. J. Bearss, M. Webster, P. Siegel, W. J. Muller, J. J. Windle, R. G. Pestell, and M. P. Lisanti
Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo. IMPLICATIONS FOR HUMAN BREAST CANCER
J. Biol. Chem.,
August 7, 1998;
273(32):
20448 - 20455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Waugh, D. Lawson, S. K. Tan, and J. J. Hsuan
Phosphatidylinositol 4-Phosphate Synthesis in Immunoisolated Caveolae-like Vesicles and Low Buoyant Density Non-caveolar Membranes
J. Biol. Chem.,
July 3, 1998;
273(27):
17115 - 17121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Wolf, M. G. Jobling, S. Wimer-Mackin, M. Ferguson-Maltzman, J. L. Madara, R. K. Holmes, and W. I. Lencer
Ganglioside Structure Dictates Signal Transduction by Cholera Toxin and Association with Caveolae-like Membrane Domains in Polarized Epithelia
J. Cell Biol.,
May 18, 1998;
141(4):
917 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Isshiki, J. Ando, R. Korenaga, H. Kogo, T. Fujimoto, T. Fujita, and A. Kamiya
Endothelial Ca2+ waves preferentially originate at specific loci in caveolin-rich cell edges
PNAS,
April 28, 1998;
95(9):
5009 - 5014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Oh, D. P. McIntosh, and J. E. Schnitzer
Dynamin at the Neck of Caveolae Mediates Their Budding to Form Transport Vesicles by GTP-driven Fission from the Plasma Membrane of Endothelium
J. Cell Biol.,
April 6, 1998;
141(1):
101 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Okamoto, A. Schlegel, P. E. Scherer, and M. P. Lisanti
Caveolins, a Family of Scaffolding Proteins for Organizing "Preassembled Signaling Complexes" at the Plasma Membrane
J. Biol. Chem.,
March 6, 1998;
273(10):
5419 - 5422.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Civenni, S. T. Test, U. Brodbeck, and P. Butikofer
In Vitro Incorporation of GPI-Anchored Proteins Into Human Erythrocytes and Their Fate in the Membrane
Blood,
March 1, 1998;
91(5):
1784 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Esser, K. Wolburg, H. Wolburg, G. Breier, T. Kurzchalia, and W. Risau
Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
J. Cell Biol.,
February 23, 1998;
140(4):
947 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Deans, S. M. Robbins, M. J. Polyak, and J. A. Savage
Rapid Redistribution of CD20 to a Low Density Detergent-insoluble Membrane Compartment
J. Biol. Chem.,
January 2, 1998;
273(1):
344 - 348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Brown
Sphingolipid organization in biomembranes: what physical studies of model membranes reveal
J. Cell Sci.,
January 1, 1998;
111(1):
1 - 9.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Oka, M. Yamamoto, C. Schwencke, J.-i. Kawabe, T. Ebina, S. Ohno, J. Couet, M. P. Lisanti, and Y. Ishikawa
Caveolin Interaction with Protein Kinase C. ISOENZYME-DEPENDENT REGULATION OF KINASE ACTIVITY BY THE CAVEOLIN SCAFFOLDING DOMAIN PEPTIDE
J. Biol. Chem.,
December 26, 1997;
272(52):
33416 - 33421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Stauffer and T. Meyer
Compartmentalized IgE Receptor-mediated Signal Transduction in Living Cells
J. Cell Biol.,
December 15, 1997;
139(6):
1447 - 1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Mastick and A. R. Saltiel
Insulin-stimulated Tyrosine Phosphorylation of Caveolin Is Specific for the Differentiated Adipocyte Phenotype in 3T3-L1 Cells
J. Biol. Chem.,
August 15, 1997;
272(33):
20706 - 20714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pol, A. Lu, M. Pons, S. Peiro, and C. Enrich
Epidermal Growth Factor-mediated Caveolin Recruitment to Early Endosomes and MAPK Activation. ROLE OF CHOLESTEROL AND ACTIN CYTOSKELETON
J. Biol. Chem.,
September 22, 2000;
275(39):
30566 - 30572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. P. Henderson, L. Lin, A. Prasad, C. A. Paul, T. Y. Chang, and R. A. Maue
Embryonic Striatal Neurons from Niemann-Pick Type C Mice Exhibit Defects in Cholesterol Metabolism and Neurotrophin Responsiveness
J. Biol. Chem.,
June 23, 2000;
275(26):
20179 - 20187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ros-Baro, C. Lopez-Iglesias, S. Peiro, D. Bellido, M. Palacin, A. Zorzano, and M. Camps
Lipid rafts are required for GLUT4 internalization in adipose cells
PNAS,
October 9, 2001;
98(21):
12050 - 12055.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Matveev and E. J. Smart
Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae
Am J Physiol Cell Physiol,
April 1, 2002;
282(4):
C935 - C946.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|